ACE and sarcopenia: Our main analysis showed no significant association of sarcopenia with angiotensin converting enzyme inhibitors (ACE-Is)/angiotensin receptor blockers (ARBs) use vs. no sarcopenia (OR: 0.78, 95%CI 0.54–1.13, I2 = 45%, P = 0.19) (Figure 2).